O106 A CHEMORADIOTHERAPY TREATMENT RESPONSE MRNA SIGNATURE AS PREDICTOR FOR ESOPHAGEAL ADENOCARCINOMA TREATED ACCORDING TO THE CROSS REGIMEN

Authors :: Sybren L. Meijer
Kausilia K. Krishnadath
M. I. van Berge Henegouwen
Liudmila L. Kodach
S S Gisbertz
Silvia Calpe
J.M. Van Dieren
C M del Sancho-Serra
Hina N. Khan
J.W. van Sandick
W J Koemans
Jan Koster
Maarten C.C.M. Hulshof
H.W.M. van Laarhoven
Sanne Hoefnagel
Source :: Diseases of the Esophagus. 32
Publication Year :: 2019
Publisher :: Oxford University Press (OUP), 2019.

Subjects :: medicine.medical_specialty
Treatment response
Regimen
Messenger RNA
business.industry
Internal medicine
Gastroenterology
Medicine
Esophageal adenocarcinoma
General Medicine
business
Chemoradiotherapy

Full Text Access

Tools